Please enter mandatory and valid details

Redefining Digital Pathology
From Scanning to Diagnosis*

OS-SiA™:
The World’s First Patented AI-Powered Digital Pathology Scanner that Scans, Indexes, and Analyzes Simultaneously

The Innovation: Simultaneous Scan-Index-Analyze

OptraSCAN’s patented OS-SiA™ technology redefines the fundamentals of digital pathology by integrating artificial intelligence directly into the scanning process. OS-SiA™ combines scanning, indexing, and real-time analysis into one device and one seamless process. The technology helps labs deliver faster, more consistent results, without costly infrastructure or additional processing applications or devices. Whether it is a routine diagnostic* lab, regional center, national screening program, or mobile diagnostic* outreach clinic, OS-SiA™ makes screening more efficient, accessible, and actionable, even in low-resource settings with limited on-site expertise.

Core Capabilities:

OS-SiA™ transforms the scanner from a passive image-capture device into an active diagnostic* system. Each scanned slide becomes a source of real-time insights, reducing turnaround time, increasing efficiency, and accelerating clinical decision-making.

1.Scanning:

The scanner intelligently interacts with a slide, using 3D Z-stacking and Composite Imaging (OptraSCAN's patented extended-depth-of-field technology). It detects tissue regions, optimizes focus, and combines high-quality images captured across a whole slide in a single plane without losing any data. OS-SiA™ reduces intra- and inter-observer variability.

Scan image
Scan image

2.Slide Quality Assessment:

OS-SiA™ leverages AI to ensure every slide is diagnostically* flawless. Pre-scan integrity check automatically detects physical defects like scratches, dust, and assesses tissue preparation and staining quality. Post-scan image quality assurance validates digital focus, seamless stitching, and optimal color contrast. Finally, it generates a unified diagnostic* QC report, providing pathologists with a guarantee of quality from slide preparation to final diagnosis*, instilling complete confidence in their digital workflow.

3. Simultaneous Indexing & Meta-Data Tagging:

OS-SiA™ automatically generates indexed thumbnails, slide maps, metadata, and contextual information. Once the scan is complete, the slides are already categorized, catalogued, and made searchable. OS-SiA™ instantly tags each scanned region and prepares the database for easy integration into the lab workflow, reducing hours of processing time.

Scan image
Scan image

4.On-Device AI-Powered Analytics:

OS-SiA™ runs real-time AI analysis during scanning to provide quantitative insights through morphological measurements, segmentation of normal vs abnormal cases, triaging, and diagnostic* scoring. It provides the turnkey analysis of breast cancer (ER, PR, Ki67, HER2) (TNM staging), lung cancer (PD-L1, EGFR), p53, prostate cancer (Gleason scoring), and cervical cancer cytology (HSIL, LSIL, ASC-H, ASCUS).

By the time the slide is digitized and indexed, the AI analysis is already complete. Pathologists are presented with pre-analyzed intelligence-rich cases, prioritized by urgency and accompanied by AI-generated flags and reports. This slashes diagnostic* turnaround time from hours to minutes.

5. Flexible Viewing:

The final stitched whole slide image (WSI) is immediately and automatically pushed to IMAGEPath® (OptraSCAN’s Image Management System). Anytime anywhere, pathologists can view, pan, zoom, annotate, archive/retrieve the high-resolution small-file-size WSIs and collaborate in real-time, eliminating data storage issues and geographic limitations.

Scan image
Technical Highlights
1 Scanning mode: Brightfield
2 Magnification: 20x / 40x
3 AI assistance: Real-time analysis with clinically reliable and actionable insights
4 Image output formats: JPEG 2000, TIFF, oTIFF, DICOM
5 Integration: Bi-directional LIS, PACS, LIMS, HIS via API or HL7 protocol
6 Architecture: Cloud-enabled for telepathology and collaboration

What Challenges OS-SiA™ Tackles:

Traditional Pathology Challenges
  • Slow turnaround times
  • Linear multi-step workflow
  • Fragile physical slides + costly space-intensive storage
  • Manual QC delays & variability
Digital Workflow Challenges
  • Large files & delayed AI insights
  • Complex integration, unused data potential
OS-SiA™ Solutions
  • Real-time results from a single scan
  • Single step scan-index-analyze process
  • Digital files + digital storage + instant cloud access
  • AI-guided real-time QC with reproducible results
OS-SiA™ Solutions
  • Optimized files (~800MB) + real-time on-device AI analytics during scan
  • Automated LIS/IMS pipeline, searchable intelligence

What Makes OS-SiA™ Different

AI at Acquisition

Lightbulb Illustration

Scanning, indexing, and real-time analysis occur intra-scan (during image capture, not post-scan) in a single step

End-to-End Ecosystem

Lightbulb Illustration

Works seamlessly with OptraSCAN’s brightfield scanners (OS-SiX, OS-Lite, and OS-Ultra) and IMAGEPath®

Broad Use Versatility

Lightbulb Illustration

Designed for both clinical and research purposesBroad Use Versatility Broad Use Versatility Broad Use Versatility

Efficiency

Lightbulb Illustration

Eliminates post-processing steps, reduces human error, decreases diagnostic* TAT from hours to minutes, and maximizes throughput

Reproducibility

Lightbulb Illustration

Enhances reproducible results with consistent, AI-driven image quality for every slide every time

Scalability

Lightbulb Illustration

Automated workflow handles high-volume caseloads with ease Broad Use Versatility Broad Use Versatility Broad Use Versatility

Affordability

Lightbulb Illustration

Requires less investment and minimizes labor, storage, and rescanning costs

Trusted Globally
Lightbulb Illustration

OptraSCAN systems are certified under ISO 13485: 2016 and CE-IVD under EU-IVDR 2017/746 for select products

Where OS-SiA™ Delivers the Most Impact

  • National health screening programs scaling to millions of people
  • Public health labs which need fast, cost-effective triage
  • Mid/high-volume cytology labs boosting throughput and standardization
  • NGOs, academic institutions, and mobile screening units expanding screening access
  • Telepathology networks enabling remote expert collaboration
  • Pharma and biotech teams accelerating study timelines through instant, AI-driven results
  • Labs developing LDTs accelerating validation through consistent, real-time image analysis
Preview Image
Connect with our team for DPAC: Europe!

Please fill out the form below and complete all questions with an asterisk (*)

Please enter mandatory and valid details
Loading
Your message has been sent. Thank you!